JP2017520774A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017520774A5 JP2017520774A5 JP2017502940A JP2017502940A JP2017520774A5 JP 2017520774 A5 JP2017520774 A5 JP 2017520774A5 JP 2017502940 A JP2017502940 A JP 2017502940A JP 2017502940 A JP2017502940 A JP 2017502940A JP 2017520774 A5 JP2017520774 A5 JP 2017520774A5
- Authority
- JP
- Japan
- Prior art keywords
- level
- subject
- composition
- measured
- hypoxia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021159462A JP7208323B2 (ja) | 2014-03-28 | 2021-09-29 | Ｌ－２－ヒドロキシグルタル酸及びストレス誘発性代謝 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461972091P | 2014-03-28 | 2014-03-28 | |
| US61/972,091 | 2014-03-28 | ||
| PCT/US2015/023038 WO2015148950A1 (en) | 2014-03-28 | 2015-03-27 | L-2-hydroxyglutarate and stress induced metabolism |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021159462A Division JP7208323B2 (ja) | 2014-03-28 | 2021-09-29 | Ｌ－２－ヒドロキシグルタル酸及びストレス誘発性代謝 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017520774A JP2017520774A (ja) | 2017-07-27 |
| JP2017520774A5 true JP2017520774A5 (https=) | 2018-05-10 |
| JP6953305B2 JP6953305B2 (ja) | 2021-10-27 |
Family
ID=54196451
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017502940A Expired - Fee Related JP6953305B2 (ja) | 2014-03-28 | 2015-03-27 | Ｌ−２−ヒドロキシグルタル酸及びストレス誘発性代謝 |
| JP2021159462A Active JP7208323B2 (ja) | 2014-03-28 | 2021-09-29 | Ｌ－２－ヒドロキシグルタル酸及びストレス誘発性代謝 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021159462A Active JP7208323B2 (ja) | 2014-03-28 | 2021-09-29 | Ｌ－２－ヒドロキシグルタル酸及びストレス誘発性代謝 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10450596B2 (https=) |
| EP (1) | EP3122893B1 (https=) |
| JP (2) | JP6953305B2 (https=) |
| AU (1) | AU2015237241B2 (https=) |
| CA (1) | CA2943823C (https=) |
| WO (1) | WO2015148950A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013075065A1 (en) | 2011-11-18 | 2013-05-23 | Memorial Sloan-Kettering Cancer Center | 2-hydroxyglutarate as a biomarker for chronic hypoxia |
| US10450596B2 (en) | 2014-03-28 | 2019-10-22 | Memorial Sloan-Kettering Cancer Center | L-2-hydroxyglutarate and stress induced metabolism |
| US20200375963A1 (en) * | 2017-02-10 | 2020-12-03 | Health Research, Inc. | Targeting mitochondrial complex ii to reduce effects of chronic hypoxia |
| US10500318B1 (en) * | 2018-07-03 | 2019-12-10 | Temple Therapeutics BV | Dosing regimens for treating hypoxia-associated tissue damage |
| JP6977999B2 (ja) * | 2018-08-22 | 2021-12-08 | 国立大学法人京都大学 | 胚培養培地、及び胚培養方法 |
| FR3097739B1 (fr) * | 2019-06-25 | 2022-03-04 | Lnc Therapeutics | Bactéries du microbiote intestinal et composition en contenant pour son utilisation dans la prévention et/ou le traitement de maladies caractérisées par l’excès de 2-hydroxyglutarate |
| CN112830958B (zh) * | 2021-02-05 | 2022-06-14 | 山东大学 | 一种特异性响应于d-2-羟基戊二酸的转录调控因子及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6855510B2 (en) | 2001-03-20 | 2005-02-15 | Dana Farber Cancer Institute, Inc. | Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| US20060084123A1 (en) | 2001-12-13 | 2006-04-20 | Harris Adrian L | MN and hypoxia |
| JP2006507510A (ja) * | 2002-11-21 | 2006-03-02 | インバーネス・メデイカル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | 組織低酸素症の体液マーカー |
| WO2009086215A2 (en) | 2007-12-21 | 2009-07-09 | Wyeth | Pathway analysis of cell culture phenotypes and uses thereof |
| AU2010223919B2 (en) | 2009-03-13 | 2016-03-31 | Les Laboratoires Servier | Methods and compositions for cell-proliferation-related disorders |
| SE534542C2 (sv) | 2009-09-30 | 2011-09-27 | Calmark Sweden Ab | Testsystem för bestämning av hypoxiutlöst cellskada |
| WO2011050211A2 (en) | 2009-10-21 | 2011-04-28 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
| US20130109643A1 (en) | 2010-05-10 | 2013-05-02 | The Johns Hopkins University | Metabolic inhibitor against tumors having an idh mutation |
| US20120202883A1 (en) * | 2011-01-20 | 2012-08-09 | Duke University | Effects of idh1 and idh2 mutations on the cellular metabolome |
| WO2013075065A1 (en) * | 2011-11-18 | 2013-05-23 | Memorial Sloan-Kettering Cancer Center | 2-hydroxyglutarate as a biomarker for chronic hypoxia |
| CA2853202A1 (en) * | 2011-12-09 | 2013-06-13 | Metabolon, Inc. | Biomarkers for kidney cancer and methods using the same |
| US8977473B2 (en) | 2012-08-29 | 2015-03-10 | Caterpillar Inc. | Pressure control strategy for dual fuel compression ignition engine and machine using same |
| US10450596B2 (en) | 2014-03-28 | 2019-10-22 | Memorial Sloan-Kettering Cancer Center | L-2-hydroxyglutarate and stress induced metabolism |
-
2015
- 2015-03-27 US US15/129,167 patent/US10450596B2/en active Active
- 2015-03-27 WO PCT/US2015/023038 patent/WO2015148950A1/en not_active Ceased
- 2015-03-27 EP EP15768552.0A patent/EP3122893B1/en active Active
- 2015-03-27 CA CA2943823A patent/CA2943823C/en active Active
- 2015-03-27 JP JP2017502940A patent/JP6953305B2/ja not_active Expired - Fee Related
- 2015-03-27 AU AU2015237241A patent/AU2015237241B2/en not_active Ceased
-
2019
- 2019-06-25 US US16/452,297 patent/US11788112B2/en active Active
-
2021
- 2021-09-29 JP JP2021159462A patent/JP7208323B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017520774A5 (https=) | ||
| Gao et al. | ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells | |
| Rello et al. | Sepsis: a review of advances in management | |
| Antus | Oxidative stress markers in sputum | |
| JP2022008641A5 (https=) | ||
| Maucler et al. | In vivo D-serine hetero-exchange through alanine-serine-cysteine (ASC) transporters detected by microelectrode biosensors | |
| Dong et al. | ACE2 negatively regulates the Warburg effect and suppresses hepatocellular carcinoma progression via reducing ROS-HIF1α activity | |
| Huang et al. | Elevated serum HMGB1 in pulmonary arterial hypertension secondary to congenital heart disease | |
| Okubo et al. | Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension | |
| Zhao et al. | The lncRNA MALAT1 participates in regulating coronary slow flow endothelial dysfunction through the miR-181b-5p–MEF2A–ET-1 axis | |
| US12449425B2 (en) | Methods of treating or preventing serious symptoms from COVID-19 infection | |
| Yu et al. | Correlation of plasma vascular endothelial growth factor and endostatin levels with symptomatic intra-and extracranial atherosclerotic stenosis in a Chinese Han population | |
| Alves et al. | Vascular reactivity and ACE activity response to exercise training are modulated by the+ 9/− 9 bradykinin B2 receptor gene functional polymorphism | |
| Sharma et al. | Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I | |
| Yuhong et al. | Transcriptomic profiling reveals gene expression kinetics in patients with hypoxia and high altitude pulmonary edema | |
| Hamada et al. | Role of mitochondrial hydrogen peroxide induced by intermittent hypoxia in airway epithelial wound repair in vitro | |
| Wang et al. | Biomarkers in copd-associated ph/ccp: circulating molecules and cell-intrinsic marker | |
| Chu et al. | Association between hypoxia-inducible factor-1a levels in serum and synovial fluid with the radiographic severity of knee osteoarthritis | |
| JP2012521549A5 (https=) | ||
| Miyazawa et al. | Potential association of circulating microRNA-181c and microRNA-484 levels with cardiorespiratory fitness after myocardial infarction: a pilot study | |
| Sultan et al. | Circulating prolidase activity in patients with myocardial infarction | |
| Shah et al. | Platelet nitric oxide signalling in heart failure: role of oxidative stress | |
| Kaiser et al. | Mid-regional pro-adrenomedullin: an indicator of the failing Fontan circuit in patients with univentricular hearts? | |
| Kiranmayi et al. | Evaluation of cardiac markers in chronic renal failure | |
| Mahishale et al. | Cardiovascular profile of patients with chronic kidney disease |